Comparison between IKIO Lighting IPO and Mankind Pharma IPO.
IKIO Lighting IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Mankind Pharma IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of IKIO Lighting IPO is up to ₹606.50 Cr whereas the issue size of the Mankind Pharma IPO is up to ₹4,326.36 Cr. The final issue price of IKIO Lighting IPO is ₹285.00 per share and of Mankind Pharma IPO is ₹1,080.00 per share.
| IKIO Lighting IPO | Mankind Pharma IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹1 per share |
| Issue Price (Lower) | ₹270.00 per share | ₹1,026.00 per share |
| Issue Price (Upper) | ₹285.00 per share | ₹1,080.00 per share |
| Issue Price (Final) | ₹285.00 per share | ₹1,080.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 52 shares | 13 shares |
| Fresh Issue Size | 1,22,80,701 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹350.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 90,00,000 shares | 4,00,58,844 shares |
| OFS Issue Size (Amount) | up to ₹256.50 Cr | up to ₹4,326.36 Cr |
| Issue Size Total | 2,12,80,701 shares | 4,00,58,844 shares |
| Issue Size Total (Amount) | up to ₹606.50 Cr | up to ₹4,326.36 Cr |
IKIO Lighting IPO opens on Jun 06, 2023, while Mankind Pharma IPO opens on Apr 25, 2023. The closing date of IKIO Lighting IPO and Mankind Pharma IPO is Jun 08, 2023, and Apr 27, 2023, respectively.
| IKIO Lighting IPO | Mankind Pharma IPO | |
|---|---|---|
| Anchor Bid Date | Jun 05, 2023 | Apr 24, 2023 |
| Issue Open | Jun 06, 2023 | Apr 25, 2023 |
| Issue Close | Jun 08, 2023 | Apr 27, 2023 |
| Basis Of Allotment (Tentative) | Jun 13, 2023 | May 03, 2023 |
| Initiation of Refunds (Tentative) | Jun 14, 2023 | May 04, 2023 |
| Credit of Share (Tentative) | Jun 15, 2023 | May 05, 2023 |
| Listing date (Tentative) | Jun 16, 2023 | May 09, 2023 |
| Anchor Lockin End date 1 | Jul 13, 2023 | Jun 02, 2023 |
| Anchor Lockin End date 2 | Sep 11, 2023 | Aug 01, 2023 |
IKIO Lighting IPO P/E ratio is 32.13, as compared to Mankind Pharma IPO P/E ratio of 32.5.
| IKIO Lighting IPO | Mankind Pharma IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Proforma Consolidated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 79.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 72.46 | 76.50 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 32.13 | 32.5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹2202.50 Cr. | ₹43263.60 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 36.00% | 27.60% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 26.00% | 26.10% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.90 | ₹33.20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 36.46% | 27.70% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the IKIO Lighting IPO Retail Individual Investors (RII) are offered 74,48,246 shares while in Mankind Pharma IPO retail investors are offered 74,48,246 shares. Qualified Institutional Buyers (QIB) are offered 42,56,140 shares in IKIO Lighting IPO and 80,11,769 shares in Mankind Pharma IPO.
| IKIO Lighting IPO | Mankind Pharma IPO | |
|---|---|---|
| Anchor Investor Reservation | 63,84,209 shares | 1,20,17,652 shares |
| Market Maker Reservation | ||
| QIB | 42,56,140 shares | 80,11,769 shares |
| NII | 31,92,106 shares | 60,08,827 shares |
| RII | 74,48,246 shares | 1,40,20,596 shares |
| Employee | ||
| Others | ||
| Total | 2,12,80,701 shares | 4,00,58,844 shares |
IKIO Lighting IPO subscribed 67.75x in total, whereas Mankind Pharma IPO subscribed 15.32x.
| IKIO Lighting IPO | Mankind Pharma IPO | |
|---|---|---|
| QIB (times) | 163.06x | 49.16x |
| NII (times) | 65.38x | 3.80x |
| Big NII (times) | 69.01x | 4.99x |
| Small NII (times) | 58.13x | 1.41x |
| RII (times) | 14.31x | 0.92x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 67.75x | 15.32x |
